{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:26:22Z","timestamp":1773249982481,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A few studies have reported that maternal administration of antenatal corticosteroids increased the risk of pulmonary edema (PE). However, despite the increasing usage rate of betamethasone as antenatal corticosteroid, maternal administration of betamethasone as a risk factor for PE has not been well studied. This study aimed to evaluate how maternal backgrounds and complications, tocolytic agents, and betamethasone affect the incidence of PE during the perinatal period and determine the risk factor for PE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a single-center retrospective cohort study in Kurashiki, Japan. The study subjects were patients who had been admitted to our hospital for perinatal management including pregnancy, delivery and puerperium between 2017 and 2020. The primary outcome measure was defined as the incidence of PE during hospitalization. First, in all study subjects, Cox proportional hazards model was used to determine the risk factor for PE during the perinatal period. Next, using propensity score matching, we divided the patients into the betamethasone and betamethasone-free groups and examined the association between betamethasone use and the incidence of PE with Cox proportional hazards model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period, 4919 cases were hospitalized, and there were 16 PE cases (0.3%). In all analyzed subjects, the occurrence of PE was significantly associated with preeclampsia (hazard ratio 16.8, 95% confidence intervals (CI) 5.39\u201352.7, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and the combined use of the tocolytic agents such as ritodrine hydrochloride and magnesium sulfate, and betamethasone (hazard ratio 11.3, 95% CI 2.66\u201348.1, <jats:italic>P<\/jats:italic>\u2009=\u20090.001). In contrast, after propensity score matching, no statistically significant difference was found between the betamethasone and betamethasone-free groups in the incidence of PE (hazard ratio 3.19, 95% CI 0.67\u201315.3, <jats:italic>P<\/jats:italic>\u2009=\u20090.145).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A combined use of tocolytic agents and antenatal corticosteroids such as betamethasone may be an independent risk factor for PE during the perinatal period. On the other hand, betamethasone use alone may not be associated with the incidence of PE. When tocolytic agents and betamethasone are administrated to pregnant women, it is important to pay attention to the appearance of maternal respiratory symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04918-2","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T04:03:17Z","timestamp":1660276997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Betamethasone use and risk factors for pulmonary edema during the perinatal period: a single-center retrospective cohort study in Japan"],"prefix":"10.1186","volume":"22","author":[{"given":"Takashi","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"4918_CR1","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Williams obstetrics. 25th ed. New York: McGraw-Hill; 2018."},{"key":"4918_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2044.2012.07055.x","volume":"67","author":"AT Dennis","year":"2012","unstructured":"Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anaesthesia. 2012;67:646\u201359.","journal-title":"Anaesthesia."},{"key":"4918_CR3","first-page":"511","volume":"101","author":"AC Sciscione","year":"2003","unstructured":"Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH. Acute pulmonary edema in pregnancy. Obstet Gynecol. 2003;101:511\u20135.","journal-title":"Obstet Gynecol"},{"key":"4918_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12884-019-2352-1","volume":"19","author":"D Shigemi","year":"2019","unstructured":"Shigemi D, Aso S, Yasunaga H. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan: a retrospective cohort study using a national inpatient database. BMC Pregnancy Childbirth. 2019;19:204\u20138.","journal-title":"BMC Pregnancy Childbirth."},{"key":"4918_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1253\/circj.66.623","volume":"66","author":"HS Choi","year":"2002","unstructured":"Choi HS, Choi H, Han S, Kim HS, Lee C, Kim YY, et al. Pulmonary edema during pregnancy: unilateral presentation is not rare. Circ J. 2002;66:623\u20136.","journal-title":"Circ J"},{"key":"4918_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejogrb.2006.09.001","volume":"133","author":"D Ogunyemi","year":"2007","unstructured":"Ogunyemi D. Risk factors for acute pulmonary edema in preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2007;133:143\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4918_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0310057X8401200212","volume":"12","author":"F Hawker","year":"1984","unstructured":"Hawker F. Pulmonary oedema associated with beta 2-sympathomimetic treatment of premature labour. Anaesth Intensive Care. 1984;12:143\u201351.","journal-title":"Anaesth Intensive Care"},{"issue":"10","key":"4918_CR8","first-page":"268","volume":"65","author":"H Seki","year":"2013","unstructured":"Seki H. The measures against pregnancy-induced hypertension: the pathophysiology of nephrotic type of preeclampsia and the management of pulmonary edema in preeclampsia (in Japanese. No abstract available). Acta Obstetrica et Gynaecologica Japonica. 2013;65(10):268\u201371.","journal-title":"Acta Obstetrica et Gynaecologica Japonica"},{"issue":"5","key":"4918_CR9","first-page":"166","volume":"66","author":"K Shimizu","year":"2020","unstructured":"Shimizu K, Nanba M, Takaishi Y, Hayashi N, Yoshioka S, Yamasaki M. Acute pulmonary edema induced by a low dose of ritodrine hydrochloride: a case report. Kobe J Med Sci. 2020;66(5):166\u20139.","journal-title":"Kobe J Med Sci"},{"key":"4918_CR10","doi-asserted-by":"publisher","unstructured":"McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12(12):CD004454. https:\/\/doi.org\/10.1002\/14651858.CD004454.pub4.","DOI":"10.1002\/14651858.CD004454.pub4"},{"key":"4918_CR11","volume-title":"Guidelines for obstetrical practice","author":"Japan Society of Obstetrics and Gynecology","year":"2017","unstructured":"Japan Society of Obstetrics and Gynecology. Guidelines for obstetrical practice. Tokyo: Japan Society of Obstetrics and Gynecology; 2017."},{"key":"4918_CR12","volume-title":"Guidelines for obstetrical practice","author":"Japan Society of Obstetrics and Gynecology","year":"2020","unstructured":"Japan Society of Obstetrics and Gynecology. Guidelines for obstetrical practice. Tokyo: Japan Society of Obstetrics and Gynecology; 2020."},{"key":"4918_CR13","unstructured":"Special Report of the Neonatal Research Network of Japan Summary of the first 10 years of the network database, Neonatal Research Network of Japan and The Japan Society for Neonatal Health and Development, 2018. https:\/\/plaza.umin.ac.jp\/nrndata\/indexe.htm. Accessed 23 Dec 2021."},{"key":"4918_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14390\/jsshp.1.3","volume":"1","author":"K Watanabe","year":"2013","unstructured":"Watanabe K, Naruse K, Tanaka K, Metoki H, Suzuki Y. Outline of definition and classification of \u201cPregnancy induced Hypertension (PIH)\u201d. Hypertens Res Pregnancy. 2013;1:3\u20134.","journal-title":"Hypertens Res Pregnancy."},{"key":"4918_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.14390\/jsshp.HRP2018-014","volume":"6","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Matsubara K, Nakamoto O, et al. Outline of the new definition and classification of \u201chypertensive disorder of pregnancy (HDP)\u201d; a revised JSSHP statement of 2005. Hypertens Res Pregnancy. 2018;6:33\u20137.","journal-title":"Hypertens Res Pregnancy"},{"issue":"3","key":"4918_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"4918_CR17","doi-asserted-by":"crossref","unstructured":"Samol JM, Lambers DS. Magnesium sulfate tocolysis and pulmonary edema: the drug or the vehicle? Am J Obstet Gynecol. 2005;192:1430\u20132.","DOI":"10.1016\/j.ajog.2005.02.093"},{"key":"4918_CR18","doi-asserted-by":"crossref","unstructured":"Huscher D, Thiele K, Gromnica-Ihel E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68:1119\u201324.","DOI":"10.1136\/ard.2008.092163"},{"key":"4918_CR19","doi-asserted-by":"crossref","unstructured":"Norwitz ER, Edusa V, Park JS. Maternal physiology and complications of multiple pregnancy. Semin Perinatol. 2005;29(5):338\u201348.","DOI":"10.1053\/j.semperi.2005.08.002"},{"key":"4918_CR20","doi-asserted-by":"crossref","unstructured":"Shinohara S, Sunami R, Uchida Y, Hirata S, Suzuki K. Association between total dose of ritodrine hydrochloride and pulmonary oedema in twin pregnancy: a retrospective cohort study in Japan. BMJ Open. 2017;7:e018118.","DOI":"10.1136\/bmjopen-2017-018118"},{"key":"4918_CR21","doi-asserted-by":"crossref","unstructured":"Teefey CP, Durnwald CP, Srinivas SK, Levine LD. Adverse maternal outcomes differ between obese and nonobese women with severe preeclampsia. Am J Perinatol. 2019;36:74\u20138.","DOI":"10.1055\/s-0038-1661403"},{"key":"4918_CR22","doi-asserted-by":"crossref","unstructured":"Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71:2419\u201330.","DOI":"10.1016\/j.jacc.2018.02.076"},{"key":"4918_CR23","doi-asserted-by":"crossref","unstructured":"Ogawa K, Urayama KY, Tanigaki S, Sago H, Sato S, Saito S, et al. Association between very advanced maternal age and adverse pregnancy outcomes: a cross sectional Japanese study. BMC Pregnancy Childbirth. 2017;17:349.","DOI":"10.1186\/s12884-017-1540-0"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04918-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T04:04:18Z","timestamp":1660277058000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4918"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04918-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Kurashiki Central Hospital, Medical Ethics Committee (approval number 3778). Since it was an observational retrospective cohort study using medical records, obtaining informed consent from all the study subjects was difficult. We disclosed the contents of the study on our hospital\u2019s website as an opportunity for the subjects to withdraw their consent. This consent procedure was approved by Kurashiki Central Hospital, Medical Ethics Committee. All methods in this study were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"636"}}